The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...
The decision is a win for Lilly — which had been pressing the FDA to take the step for months — and is expected to impact ...
Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...